Literature DB >> 25543269

Syk is indispensable for CpG-induced activation and differentiation of human B cells.

Mariann Kremlitzka1, Bernadett Mácsik-Valent, Anna Erdei.   

Abstract

B cells are efficiently activated by CpG oligodeoxynucleotides (ODNs) to produce pro-inflammatory cytokines and antibody (Ab). Here, we describe a so far unidentified, spleen tyrosine kinase (Syk)-dependent pathway, which is indispensable for CpG-induced human B cell activation. We show that triggering of B cells by CpG results in Syk and src kinase phosphorylation, proliferation, as well as cytokine and Ab production independent of the BCR. Notably, all these functions are abrogated when Syk is inhibited. We demonstrate that CpG-induced Syk activation originates from the cell surface in a TLR9-dependent manner. While inhibition of Syk does not influence the uptake of CpG ODNs, activation of the kinase is a prerequisite for the delivery of CpG into TLR9-containing endolysosomes and for the CpG-induced up-regulation of TLR9 expression. Our results reveal an alternative, Syk-dependent pathway of CpG-induced B cell stimulation, which is initiated at the plasma membrane and seems to be an upstream requirement for endosomal TLR9-driven B cell proliferation and differentiation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25543269     DOI: 10.1007/s00018-014-1806-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  47 in total

Review 1.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

2.  Syk mediates BCR- and CD40-signaling integration during B cell activation.

Authors:  Haiyan Ying; Zhenping Li; Lifen Yang; Jian Zhang
Journal:  Immunobiology       Date:  2010-10-07       Impact factor: 3.144

3.  Activation of human B cells by phosphorothioate oligodeoxynucleotides.

Authors:  H Liang; Y Nishioka; C F Reich; D S Pisetsky; P E Lipsky
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

4.  DNA binding to human leukocytes. Evidence for a receptor-mediated association, internalization, and degradation of DNA.

Authors:  R M Bennett; G T Gabor; M M Merritt
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

5.  Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk.

Authors:  M Turner; P J Mee; P S Costello; O Williams; A A Price; L P Duddy; M T Furlong; R L Geahlen; V L Tybulewicz
Journal:  Nature       Date:  1995-11-16       Impact factor: 49.962

6.  BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation.

Authors:  Julia Eckl-Dorna; Facundo D Batista
Journal:  Blood       Date:  2009-01-14       Impact factor: 22.113

7.  Convergence of CpG DNA- and BCR-mediated signals at the c-Jun N-terminal kinase and NF-kappaB activation pathways: regulation by mitogen-activated protein kinases.

Authors:  Ae-Kyung Yi; Jae-Geun Yoon; Arthur M Krieg
Journal:  Int Immunol       Date:  2003-05       Impact factor: 4.823

8.  Mechanism and regulatory function of CpG signaling via scavenger receptor B1 in primary B cells.

Authors:  Peimin Zhu; Xiaohong Liu; Laura S Treml; Michael P Cancro; Bruce D Freedman
Journal:  J Biol Chem       Date:  2009-06-19       Impact factor: 5.157

9.  Phospholipase C-gamma2 and Vav cooperate within signaling microclusters to propagate B cell spreading in response to membrane-bound antigen.

Authors:  Michele Weber; Bebhinn Treanor; David Depoil; Hisaaki Shinohara; Naomi E Harwood; Masaki Hikida; Tomohiro Kurosaki; Facundo D Batista
Journal:  J Exp Med       Date:  2008-03-24       Impact factor: 14.307

10.  The BAFF receptor transduces survival signals by co-opting the B cell receptor signaling pathway.

Authors:  Edina Schweighoffer; Lesley Vanes; Josquin Nys; Doreen Cantrell; Scott McCleary; Nicholas Smithers; Victor L J Tybulewicz
Journal:  Immunity       Date:  2013-02-28       Impact factor: 31.745

View more
  9 in total

1.  BTLA Expression and Function Are Impaired on SLE B Cells.

Authors:  Annika Wiedemann; Marie Lettau; Sarah Y Weißenberg; Ana-Luisa Stefanski; Eva-Vanessa Schrezenmeier; Hector Rincon-Arevalo; Karin Reiter; Tobias Alexander; Falk Hiepe; Andreia C Lino; Thomas Dörner
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

2.  A human tissue-based functional assay platform to evaluate the immune function impact of small molecule inhibitors that target the immune system.

Authors:  Cristina St Pierre; Jane Guo; John D Shin; Laura W Engstrom; Hyun-Hee Lee; Alan Herbert; Laura Surdi; James Baker; Michael Salmon; Sanjiv Shah; J Michael Ellis; Hani Houshyar; Michael A Crackower; Melanie A Kleinschek; Dallas C Jones; Alexandra Hicks; Dennis M Zaller; Stephen E Alves; Ravisankar A Ramadas
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

Review 3.  TLR7/TLR9- and B Cell Receptor-Signaling Crosstalk: Promotion of Potentially Dangerous B Cells.

Authors:  Amy N Suthers; Stefanie Sarantopoulos
Journal:  Front Immunol       Date:  2017-07-13       Impact factor: 7.561

4.  STIM1 promotes migration, phagosomal maturation and antigen cross-presentation in dendritic cells.

Authors:  Paula Nunes-Hasler; Sophia Maschalidi; Carla Lippens; Cyril Castelbou; Samuel Bouvet; Daniele Guido; Flavien Bermont; Esen Y Bassoy; Nicolas Page; Doron Merkler; Stéphanie Hugues; Denis Martinvalet; Bénédicte Manoury; Nicolas Demaurex
Journal:  Nat Commun       Date:  2017-11-24       Impact factor: 14.919

5.  Identification and Characterization of Post-activated B Cells in Systemic Autoimmune Diseases.

Authors:  Sarah Y Weißenberg; Franziska Szelinski; Eva Schrezenmeier; Ana-Luisa Stefanski; Annika Wiedemann; Hector Rincon-Arevalo; Anna Welle; Annemarie Jungmann; Karl Nordström; Jörn Walter; Juliana Imgenberg-Kreuz; Gunnel Nordmark; Lars Rönnblom; Prathyusha Bachali; Michelle D Catalina; Amrie C Grammer; Peter E Lipsky; Andreia C Lino; Thomas Dörner
Journal:  Front Immunol       Date:  2019-09-24       Impact factor: 7.561

6.  Complement Receptor Type 1 (CR1, CD35), the Inhibitor of BCR-Mediated Human B Cell Activation, Differentially Regulates TLR7, and TLR9 Induced Responses.

Authors:  Bernadett Mácsik-Valent; Katinka Nagy; László Fazekas; Anna Erdei
Journal:  Front Immunol       Date:  2019-07-02       Impact factor: 7.561

7.  Human IgA-Expressing Bone Marrow Plasma Cells Characteristically Upregulate Programmed Cell Death Protein-1 Upon B Cell Receptor Stimulation.

Authors:  Annika Wiedemann; Marie Lettau; Ina Wirries; Annemarie Jungmann; Abdulrahman Salhab; Gilles Gasparoni; Henrik E Mei; Carsten Perka; Jörn Walter; Andreas Radbruch; Andreia C Lino; Thomas Dörner
Journal:  Front Immunol       Date:  2021-02-12       Impact factor: 7.561

8.  Characterization of the mechanism of action of lanraplenib, a novel spleen tyrosine kinase inhibitor, in models of lupus nephritis.

Authors:  Christopher W Pohlmeyer; Ching Shang; Pei Han; Zhi-Hua Cui; Randall M Jones; Astrid S Clarke; Bernard P Murray; David A Lopez; David W Newstrom; M David Inzunza; Franziska G Matzkies; Kevin S Currie; Julie A Di Paolo
Journal:  BMC Rheumatol       Date:  2021-03-30

Review 9.  Therapeutic implications of the anergic/postactivated status of B cells in systemic lupus erythematosus.

Authors:  Thomas Dörner; Franziska Szelinski; Andreia C Lino; Peter E Lipsky
Journal:  RMD Open       Date:  2020-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.